The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study

Sponsor
American Cancer Society, Inc. (Other)
Overall Status
Completed
CT.gov ID
NCT03345264
Collaborator
Will2Love, LLC (Other)
361
1
1
14.3
25.3

Study Details

Study Description

Brief Summary

Concerns with sexual health and fertility are common among cancer patients, survivors and their partners. Literature reviews suggest that over 60% of survivors have reproductive health problems yet fewer than 20% get professional help. This study will test the uptake, use and effectiveness of online, interactive self-help programs for men and women with cancer. Participants in the study will receive up to 6 months of access to the self-help programs without charge. Navigation through the programs can be personalized by setting goals and following links to the most relevant information. The programs cover all cancer sites and common treatments, explaining sexual and fertility side effects. Programs also include step-by-step cognitive behavioral self-help exercises, guidance on available medical treatment options, decision aids, and video stories with actual survivors as well as vignettes with actors. Information for same-sex couples is included. Programs include suggestions on how partners can work together to cope with sexual or fertility issues.

The primary hypothesis is that participants will report improvements in sexual function and satisfaction from baseline to 3-month follow-up. Secondary hypotheses will investigate whether more extensive use of the program is associated with better outcomes (dose-response effect) and whether the intervention also improves secondary outcomes such as anxiety, depression, relationship satisfaction, and seeking medical help. Analyses from the data will investigate how many people who are informed of the study decide to participate (uptake), as well as how often participants visit the program and which parts are used most. Both the male and female programs have previously been shown to help cancer survivors and partners in published clinical trials.

Participants will be encouraged to invite a sexual partner to join the study, but that will be optional. Partners will be able to be linked for statistical analysis through their unique study identification numbers. Participants' use of the websites will be electronically tracked and compared with questionnaire outcome measures. Outcome measures include online, self-report questionnaires completed at baseline and 3-month follow-up. At 6-month follow-up, participants will complete 2 online ratings of the helpfulness of the programs. Privacy and security are carefully protected. The entire website meets standards for HIPAA (Health Insurance Portability and Accountability Act). Questionnaires are identified with study numbers rather than names or email addresses. Once the study data are analyzed, the list linking participant identifying information (names, email) and study numbers will be destroyed. Any publications resulting from the study will discuss group data and will not contain any information that could be used to identify an individual participant.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Online, interactive self-help program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
361 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
Actual Study Start Date :
Oct 2, 2017
Actual Primary Completion Date :
Sep 11, 2018
Actual Study Completion Date :
Dec 11, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cancer patients, survivors, and partners

Behavioral: Online, interactive self-help program
Participants will receive access to the program, which provides: In-depth information specific to cancer sites and treatments, guidance on medical options for cancer-related sex or fertility problems, personalized goal-setting with progress tracking and relapse prevention, self-help exercises on overcoming sexual, relationship, and dating problems, videos of survivors' stories, and video vignettes with actors.

Outcome Measures

Primary Outcome Measures

  1. PROMIS® (Patient-Reported Outcomes Measurement Information System) Brief Sexual Profile v2 Male [Change from baseline to 3 months post consent]

    Construct: Sexual function and satisfaction in men; Total Score Range: 0-33; Higher values represent a better outcome

  2. PROMIS® (Patient-Reported Outcomes Measurement Information System) Brief Sexual Profile v2 Female [Change from baseline to 3 months post consent]

    Construct: Sexual function and satisfaction in women; Total Score Range: 0-49; Higher values represent a better outcome

Secondary Outcome Measures

  1. PROMIS® (Patient-Reported Outcomes Measurement Information System) Brief Anxiety Scale [Change from baseline to 3 months post consent]

    Construct: General anxiety level; Total Score Range: 0-16; Higher scores represent a worse outcome

  2. PROMIS® (Patient-Reported Outcomes Measurement Information System) Brief Depression Scale [Change from baseline to 3 months post consent]

    Construct: Depressed Mood; Total Score Range: 0-16; Higher scores represent a worse outcome

  3. Abbreviated Dyadic Adjustment Scale-4 [Change from baseline to 3 months post consent]

    Construct: Relationship happiness; Total Score Range: 0-21; Higher scores represent a better outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Has had a diagnosis of cancer or is the intimate partner of a cancer patient/survivor

  • Has a concern or wants to learn more about cancer-related issues with sexuality or fertility

  • Has a way to access the website and questionnaires on the internet

Exclusion Criteria:
  • Younger than age 18

  • Does not read and understand English well enough to use the website independently

  • Does not live in the United States

  • Potential participant has already subscribed to the male or female self-help program

Contacts and Locations

Locations

Site City State Country Postal Code
1 Will2Love, LLC Houston Texas United States 77025

Sponsors and Collaborators

  • American Cancer Society, Inc.
  • Will2Love, LLC

Investigators

  • Principal Investigator: Tenbroeck Smith, American Cancer Society, Inc.
  • Principal Investigator: Leslie Schover, Will2Love, LLC

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
American Cancer Society, Inc.
ClinicalTrials.gov Identifier:
NCT03345264
Other Study ID Numbers:
  • PATHS IRB1094101
First Posted:
Nov 17, 2017
Last Update Posted:
Jan 16, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by American Cancer Society, Inc.

Study Results

No Results Posted as of Jan 16, 2019